DAIICHI SANKYO COMPANY, LIMITED (President and representative director: Takashi Shoda) and Lead Chemical Co., Ltd. (President: Masao Mori) today announced that they received an approval for manufacture and marketing of the percutaneous absorption-type analgesic and anti-inflammatory preparation, Loxonin® Tape 50mg/100mg (generic name: loxoprofen sodium) by the Japanese Ministry of Health, Labour and Welfare on March 7, 2008. The product is jointly developed by both firms.
Loxonin® Tape is the first loxoprofen sodium adhesive tape in Japan containing the same constituents as Loxonin® pills and Loxonin® powder which are leading agents among orally administered analgesic and anti-inflammatory drugs. The adhesive tape is expected to have superior analgesic and anti-inflammatory efficacy when applied once per day.
Following the launch of Loxonin® Pap in 2006, we are confident that this new addition to the long-standing top brand Loxonin® will further contribute to analgesic and anti-inflammatory drug treatment.
This preparation is scheduled to be manufactured by Lead Chemical and sold by DAIICHI SANKYO.
No comments:
Post a Comment